• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coronary microvascular dysfunction in hypertrophic cardiomyopathy detected by Rubidium-82 positron emission tomography and cardiac magnetic resonance imaging.

作者信息

Moody William E, Schmitt Matthias, Arumugam Parthiban

机构信息

Department of Cardiology, Nuffield House, Queen Elizabeth Hospital Birmingham, Birmingham, B15 2TH, UK.

Nuclear Medicine Centre, Manchester Royal Infirmary, Manchester, M13 9WL, UK.

出版信息

J Nucl Cardiol. 2019 Apr;26(2):666-670. doi: 10.1007/s12350-018-1245-4. Epub 2018 Mar 7.

DOI:10.1007/s12350-018-1245-4
PMID:29516367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6430745/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc67/6430745/5cdbd8768ccb/12350_2018_1245_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc67/6430745/7cc632197671/12350_2018_1245_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc67/6430745/9eb83d6c93a6/12350_2018_1245_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc67/6430745/77565f33d393/12350_2018_1245_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc67/6430745/5cdbd8768ccb/12350_2018_1245_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc67/6430745/7cc632197671/12350_2018_1245_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc67/6430745/9eb83d6c93a6/12350_2018_1245_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc67/6430745/77565f33d393/12350_2018_1245_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc67/6430745/5cdbd8768ccb/12350_2018_1245_Fig4_HTML.jpg

相似文献

1
Coronary microvascular dysfunction in hypertrophic cardiomyopathy detected by Rubidium-82 positron emission tomography and cardiac magnetic resonance imaging.通过铷-82正电子发射断层扫描和心脏磁共振成像检测肥厚型心肌病中的冠状动脉微血管功能障碍。
J Nucl Cardiol. 2019 Apr;26(2):666-670. doi: 10.1007/s12350-018-1245-4. Epub 2018 Mar 7.
2
3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.3.0 T磁共振心肌灌注成像用于肥厚型心肌病冠状动脉微血管功能障碍的半定量评估
Int J Cardiovasc Imaging. 2017 Dec;33(12):1949-1959. doi: 10.1007/s10554-017-1189-9. Epub 2017 Jun 13.
3
Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?心脏正电子发射断层扫描在肥厚型心肌病中的作用如何？
J Nucl Cardiol. 2019 Aug;26(4):1125-1134. doi: 10.1007/s12350-018-1298-4. Epub 2018 May 14.
4
Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact.肥厚型心肌病中的冠状动脉微血管功能障碍：病理生理学、评估和临床影响。
Microcirculation. 2021 Jan;28(1):e12656. doi: 10.1111/micc.12656. Epub 2020 Sep 22.
5
Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.肥厚型心肌病中磁共振延迟增强与正电子发射断层扫描心肌灌注的关系。
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):210-7. doi: 10.1161/CIRCIMAGING.112.000110. Epub 2013 Feb 15.
6
Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者冠状动脉微血管功能障碍与延迟强化之间的空间关系。
J Nucl Med. 2008 Jul;49(7):1090-6. doi: 10.2967/jnumed.107.050138. Epub 2008 Jun 13.
7
Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.肥厚型心肌病心力衰竭的心血管磁共振预测因子：心肌替换纤维化和微循环的作用。
J Cardiovasc Magn Reson. 2021 Mar 8;23(1):26. doi: 10.1186/s12968-021-00720-9.
8
Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.酒精室间隔消融术对肥厚型梗阻性心肌病患者冠状动脉微血管功能和心肌能量代谢的影响。
Am J Physiol Heart Circ Physiol. 2011 Jul;301(1):H129-37. doi: 10.1152/ajpheart.00077.2011. Epub 2011 Apr 13.
9
Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.肥厚型心肌病中的冠状动脉微血管缺血——一项逐像素定量心血管磁共振灌注研究
J Cardiovasc Magn Reson. 2014 Aug 12;16(1):49. doi: 10.1186/s12968-014-0049-1.
10
Hypertrophic cardiomyopathy mimicking STEMI: The role of cardiac magnetic resonance imaging in the detection of microvascular coronary dysfunction.
Diagn Interv Imaging. 2014 Nov;95(11):1111-2. doi: 10.1016/j.diii.2013.12.020. Epub 2014 Feb 20.

引用本文的文献

1
Ischemic Myocardial Positron Emission Tomography Perfusion Without Epicardial Coronary Disease in Hypertrophic Obstructive Cardiomyopathy.肥厚型梗阻性心肌病患者无冠状动脉疾病时的缺血性心肌正电子发射断层显像灌注
Cureus. 2024 Jan 16;16(1):e52401. doi: 10.7759/cureus.52401. eCollection 2024 Jan.
2
Right atrial function assessed by volume-derived values and speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者通过容量相关值和斑点追踪超声心动图评估右心房功能。
BMC Cardiovasc Disord. 2020 Jul 13;20(1):335. doi: 10.1186/s12872-020-01610-1.

本文引用的文献

1
Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by N-Ammonia Perfusion PET in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者中，通过N-氨灌注PET评估弥漫性心内膜下灌注不足对左心室腔大小的影响。
Am J Cardiol. 2016 Dec 15;118(12):1908-1915. doi: 10.1016/j.amjcard.2016.08.085. Epub 2016 Sep 15.
2
Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms.肥厚型心肌病患者在PET/CT检查时出现的左心室腔明显扩张：临床预测因素及潜在机制
J Nucl Cardiol. 2016 Dec;23(6):1304-1314. doi: 10.1007/s12350-015-0158-8. Epub 2015 May 20.
3
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
2014年欧洲心脏病学会（ESC）肥厚型心肌病诊断和治疗指南：欧洲心脏病学会（ESC）肥厚型心肌病诊断和治疗工作组
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
4
Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.肥厚型心肌病中的冠状动脉微血管缺血——一项逐像素定量心血管磁共振灌注研究
J Cardiovasc Magn Reson. 2014 Aug 12;16(1):49. doi: 10.1186/s12968-014-0049-1.
5
PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.PET/CT 评估梗阻性和非梗阻性肥厚型心肌病有症状患者。
J Nucl Med. 2012 Mar;53(3):407-14. doi: 10.2967/jnumed.111.096156. Epub 2012 Feb 7.
6
The case for myocardial ischemia in hypertrophic cardiomyopathy.肥厚型心肌病中心肌缺血的情况。
J Am Coll Cardiol. 2009 Aug 25;54(9):866-75. doi: 10.1016/j.jacc.2009.04.072.
7
Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者冠状动脉微血管功能障碍与延迟强化之间的空间关系。
J Nucl Med. 2008 Jul;49(7):1090-6. doi: 10.2967/jnumed.107.050138. Epub 2008 Jun 13.
8
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.肥厚型心肌病中的冠状动脉微血管功能障碍与预后
N Engl J Med. 2003 Sep 11;349(11):1027-35. doi: 10.1056/NEJMoa025050.